-
Why Viking Therapeutics Stock Is Soaring Tuesday
Tuesday, March 28, 2023 - 8:37am | 412Read More...Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of various metabolic disorders. What To Know: Viking said the Phase 1 single ascending dose and multiple...
-
Viking Therapeutics Gains 5% As Company Highlights Positive Data From A Phase 1b Clinical Trial
Monday, April 11, 2016 - 10:41am | 312Read More...Shares of Viking Therapeutics Inc (NASDAQ: VKTX), a clinical stage biopharmaceutical company that focuses on the treatment of metabolic and endocrine disorders, gained more than 5 percent on Monday. Viking Therapeutics highlighted positive data from a phase 1b clinical trial of VK2809 in...
